Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Mabwell initiates first-in-human study of 9MW-1411

May 13, 2021

Inovio reports preclinical data on next-generation pan-COVID-19 vaccine candidate INO-4802

May 13, 2021

New anti-HBV compounds identified at Sunshine Lake Pharma

May 13, 2021

ReViral synthesizes new benzodiazepine derivatives

May 13, 2021

NVX-CoV2373 vaccine shows efficacy against the B.1.351 variant of COVID-19

May 12, 2021

Takeda reports interim Japanese phase I/II data on Moderna's mRNA COVID-19 vaccine candidate

May 12, 2021

Novartis patents new antimalarials

May 12, 2021

COVID-19 vaccine EXG-5003 enters first-in-human study

May 12, 2021

SARS-CoV-2 vaccines make progress in the young, the old, the in-between

May 11, 2021

FDA authorizes Pfizer and BioNTech's COVID-19 vaccine for adolescents aged 12-15 years

May 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...